NextPlat Corp (NASDAQ:NXPL) Short Interest Update

NextPlat Corp (NASDAQ:NXPL) saw a significant drop in short interest in February. As of February 15th, there was short interest totalling 115,500 shares, a drop of 13.7% from the January 31st total of 133,800 shares. Currently, 0.8% of the company’s stock are short sold. Based on an average trading volume of 379,600 shares, the short-interest ratio is presently 0.3 days.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Renaissance Technologies LLC acquired a new stake in NextPlat in the fourth quarter worth about $30,000. Geode Capital Management LLC raised its position in shares of NextPlat by 54.6% in the 4th quarter. Geode Capital Management LLC now owns 165,459 shares of the company’s stock valued at $179,000 after purchasing an additional 58,402 shares during the last quarter. Finally, Omnia Family Wealth LLC acquired a new stake in NextPlat in the 3rd quarter worth approximately $132,000. 1.30% of the stock is currently owned by hedge funds and other institutional investors.

NextPlat Price Performance

NASDAQ NXPL opened at $0.92 on Wednesday. NextPlat has a 12-month low of $0.71 and a 12-month high of $2.68. The firm’s fifty day simple moving average is $1.10 and its two-hundred day simple moving average is $1.13. The company has a current ratio of 3.70, a quick ratio of 3.04 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $23.89 million, a P/E ratio of -1.35 and a beta of 0.76.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.